Early bactericidal activity as a method of assessment of drugs for the treatment of tuberculosis.
S H
SH
Gillespie
N
N
Kennedy
D000890:Anti-Infective Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical / Q000379:methods; D007538:Isoniazid / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D011237:Predictive Value of Tests; D011718:Pyrazinamide / Q000494:pharmacology; D017828:Rifabutin / Q000494:pharmacology; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*
D000890:Anti-Infective Agents; D017828:Rifabutin; D011718:Pyrazinamide; D002939:Ciprofloxacin; D007538:Isoniazid